The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1LIFE HEALTHCARE INC | COM | 68269G107 | 20,315 | 519,844 | SH | SOLE | 519,844 | 0 | 0 | ||
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 19,298 | 444,878 | SH | SOLE | 444,878 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 36,386 | 1,410,305 | SH | SOLE | 1,410,305 | 0 | 0 | ||
ACCOLADE INC | COM | 00437E102 | 15,686 | 345,741 | SH | SOLE | 345,741 | 0 | 0 | ||
ACHILLES THERAPEUTICS PLC | SPONSORED ADS | 00449L102 | 12,501 | 755,375 | SH | SOLE | 755,375 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 16,380 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 14,204 | 352,804 | SH | SOLE | 352,804 | 0 | 0 | ||
ADMA BIOLOGICS INC | COM | 000899104 | 29,189 | 16,584,802 | SH | SOLE | 16,584,802 | 0 | 0 | ||
AGILE THERAPEUTICS INC | COM | 00847L100 | 33,113 | 15,919,925 | SH | SOLE | 15,919,925 | 0 | 0 | ||
ALBIREO PHARMA INC | COM | 01345P106 | 83,195 | 2,360,139 | SH | SOLE | 2,360,139 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 103,402 | 8,703,879 | SH | SOLE | 8,703,879 | 0 | 0 | ||
ALPHATEC HOLDINGS INC | COM NEW | 02081G201 | 25,490 | 1,800,180 | SH | SOLE | 1,800,180 | 0 | 0 | ||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 40,376 | 1,143,790 | SH | SOLE | 1,143,790 | 0 | 0 | ||
AMERICAN WELL CORP | CL A | 03044L105 | 6,166 | 355,000 | SH | SOLE | 355,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 225,870 | 22,861,329 | SH | SOLE | 22,861,329 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 39,900 | 575,007 | SH | SOLE | 575,007 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 27,143 | 409,341 | SH | SOLE | 409,341 | 0 | 0 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 184,693 | 3,109,224 | SH | SOLE | 3,109,224 | 0 | 0 | ||
ATHENEX INC | COM | 04685N103 | 57,330 | 13,532,467 | SH | SOLE | 13,532,467 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 63,037 | 3,425,916 | SH | SOLE | 3,425,916 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 23,970 | 1,099,028 | SH | SOLE | 1,099,028 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 10,570 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
BCTG ACQUISITION CORP | COM | 05492W103 | 5,560 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
BEAM THERAPEUTICS INC | COM | 07373V105 | 37,832 | 537,635 | SH | SOLE | 537,635 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 209,253 | 748,000 | SH | Call | SOLE | 748,000 | 0 | 0 | |
BIOGEN INC | COM | 09062X103 | 167,850 | 600,000 | SH | Put | SOLE | 600,000 | 0 | 0 | |
BRIDGEBIO PHARMA INC | COM | 10806X102 | 477,827 | 7,756,928 | SH | SOLE | 7,756,928 | 0 | 0 | ||
BUTTERFLY NETWORK INC | *W EXP 05/27/202 | 124155110 | 1,505 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 116,835 | 3,158,566 | SH | SOLE | 3,158,566 | 0 | 0 | ||
CATABASIS PHARMACEUTICALS IN | COM NEW | 14875P206 | 5,588 | 1,933,551 | SH | SOLE | 1,933,551 | 0 | 0 | ||
CEL-SCI CORP | COM PAR NEW | 150837607 | 513 | 33,700 | SH | SOLE | 33,700 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | *W EXP 06/09/202 | 15678U102 | 573 | 133,066 | SH | SOLE | 133,066 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 63,749 | 4,643,095 | SH | SOLE | 4,643,095 | 0 | 0 | ||
CLOVER HEALTH INVESTMENTS CO | COM CL A | 18914F103 | 10,322 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
CM LIFE SCIENCES II INC | UNIT 02/25/2028 | 125842203 | 16,000 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
CM LIFE SCIENCES INC | COM CL A | 18978W109 | 1,891 | 127,000 | SH | SOLE | 127,000 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 27,997 | 3,188,750 | SH | SOLE | 3,188,750 | 0 | 0 | ||
COHERUS BIOSCIENCES INC | COM | 19249H103 | 68,632 | 4,697,612 | SH | SOLE | 4,697,612 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 23,185 | 978,277 | SH | SOLE | 978,277 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL INC | NOTE 2.625% 2/1 | 19459JAA2 | 189,560 | 17,500,000 | PRN | SOLE | 17,500,000 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 29,360 | 797,404 | SH | SOLE | 797,404 | 0 | 0 | ||
CONCERT PHARMACEUTICALS INC | COM | 206022105 | 10,731 | 2,150,641 | SH | SOLE | 2,150,641 | 0 | 0 | ||
CONSONANCE HFW ACQUISITION C | UNIT 99/99/9999 | G2445M129 | 4,880 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 51,606 | 3,659,381 | SH | SOLE | 3,659,381 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 16,650 | 2,153,974 | SH | SOLE | 2,153,974 | 0 | 0 | ||
DARIOHEALTH CORP | COM NEW | 23725P209 | 6,314 | 327,869 | SH | SOLE | 327,869 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 41,017 | 7,695,505 | SH | SOLE | 7,695,505 | 0 | 0 | ||
DEERFIELD HEALTHCARE TECH AC | COM CL A | 244413100 | 242 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
DEERFIELD HEALTHCARE TECH AC | UNIT 07/16/2025 | 244413209 | 3,930 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 20,456 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 1,238 | 139,890 | SH | SOLE | 139,890 | 0 | 0 | ||
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 61,735 | 987,287 | SH | SOLE | 987,287 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 46,587 | 353,523 | SH | SOLE | 353,523 | 0 | 0 | ||
FERRARI N V | COM | N3167Y103 | 1,298 | 6,200 | SH | SOLE | 6,200 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 6,942 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
FORMA THERAPEUTICS HOLDINGS | SHS | 34633R104 | 35,025 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
FORTE BIOSCIENCES INC | COM | 34962G109 | 23,475 | 685,000 | SH | SOLE | 685,000 | 0 | 0 | ||
FREQUENCY THERAPEUTICS INC | COM | 35803L108 | 20,080 | 2,113,661 | SH | SOLE | 2,113,661 | 0 | 0 | ||
FUSION PHARMACEUTICALS INC | COM | 36118A100 | 20,905 | 1,950,167 | SH | SOLE | 1,950,167 | 0 | 0 | ||
GALERA THERAPEUTICS INC | COM | 36338D108 | 2,246 | 254,664 | SH | SOLE | 254,664 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 206,139 | 5,058,642 | SH | SOLE | 5,058,642 | 0 | 0 | ||
HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 10,298 | 311,673 | SH | SOLE | 311,673 | 0 | 0 | ||
HEALTH CATALYST INC | COM | 42225T107 | 23,670 | 506,084 | SH | SOLE | 506,084 | 0 | 0 | ||
HEALTHCOR CATALIO ACQU CORP | CL A SHRS | G44125105 | 14,880 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 5,036 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 188,682 | 2,050,002 | SH | SOLE | 2,050,002 | 0 | 0 | ||
IMMATICS N.V | SHS | N44445109 | 28,025 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 17,028 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
INARI MED INC | COM | 45332Y109 | 60,467 | 565,113 | SH | SOLE | 565,113 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 204,831 | 5,360,673 | SH | SOLE | 5,360,673 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 273,915 | 8,651,785 | SH | SOLE | 8,651,785 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 28,338 | 4,585,512 | SH | SOLE | 4,585,512 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 61,117 | 15,711,334 | SH | SOLE | 15,711,334 | 0 | 0 | ||
KODIAK SCIENCES INC | COM | 50015M109 | 44,110 | 389,008 | SH | SOLE | 389,008 | 0 | 0 | ||
KRONOS BIO INC | COM | 50107A104 | 79,671 | 2,780,097 | SH | SOLE | 2,780,097 | 0 | 0 | ||
LANDOS BIOPHARMA INC | COM | 515069102 | 140,967 | 14,869,915 | SH | SOLE | 14,869,915 | 0 | 0 | ||
LEAP THERAPEUTICS INC | COM | 52187K101 | 16,105 | 8,476,496 | SH | SOLE | 8,476,496 | 0 | 0 | ||
LIFESCI ACQUISITION II CORP | COM | 53229E103 | 3,042 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
LONGVIEW ACQUISITION CORP II | UNIT 99/99/9999 | 54319Q204 | 5,020 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
LYRA THERAPEUTICS INC | COM | 55234L105 | 37,349 | 3,222,560 | SH | SOLE | 3,222,560 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 68,416 | 2,148,060 | SH | SOLE | 2,148,060 | 0 | 0 | ||
MEIRAGTX HLDGS PLC | COM | G59665102 | 93,374 | 6,933,277 | SH | SOLE | 6,933,277 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 20,220 | 6,000,000 | SH | SOLE | 6,000,000 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 3,655 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 595,183 | 3,474,505 | SH | SOLE | 3,474,505 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 59,365 | 938,140 | SH | SOLE | 938,140 | 0 | 0 | ||
MOTUS GI HLDGS INC | COM | 62014P108 | 2,070 | 1,800,542 | SH | SOLE | 1,800,542 | 0 | 0 | ||
NANOBIOTIX SA | SPONSORED ADS | 63009J107 | 15,939 | 1,059,800 | SH | SOLE | 1,059,800 | 0 | 0 | ||
NEPTUNE WELLNESS SOLUTIONS I | COM | 64079L105 | 16,555 | 12,849,706 | SH | SOLE | 12,849,706 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 91,593 | 941,832 | SH | SOLE | 941,832 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 113,295 | 812,154 | SH | SOLE | 812,154 | 0 | 0 | ||
NEVRO CORP | NOTE 2.750% 4/0 | 64157FAC7 | 135,324 | 9,000,000 | PRN | SOLE | 9,000,000 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 29,041 | 3,041,004 | SH | SOLE | 3,041,004 | 0 | 0 | ||
ONCORUS INC | COM | 68236R103 | 27,700 | 1,989,987 | SH | SOLE | 1,989,987 | 0 | 0 | ||
OUTSET MED INC | COM | 690145107 | 129,858 | 2,387,535 | SH | SOLE | 2,387,535 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 755 | 27,000 | SH | SOLE | 27,000 | 0 | 0 | ||
PHREESIA INC | COM | 71944F106 | 5,210 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
PLX PHARMA INC | COM | 72942A107 | 2,006 | 222,180 | SH | SOLE | 222,180 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 24,554 | 746,557 | SH | SOLE | 746,557 | 0 | 0 | ||
POSEIDA THERAPEUTICS INC | COM | 73730P108 | 7,523 | 787,745 | SH | SOLE | 787,745 | 0 | 0 | ||
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 55,354 | 3,314,032 | SH | SOLE | 3,314,032 | 0 | 0 | ||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 6,637 | 421,642 | SH | SOLE | 421,642 | 0 | 0 | ||
PROVENTION BIO INC | COM | 74374N102 | 29,932 | 2,852,058 | SH | SOLE | 2,852,058 | 0 | 0 | ||
QUOTIENT LTD | SHS | G73268107 | 59,619 | 16,200,818 | SH | SOLE | 16,200,818 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 55,000 | 2,477,481 | SH | SOLE | 2,477,481 | 0 | 0 | ||
REGENXBIO INC | COM | 75901B107 | 2,363 | 69,283 | SH | SOLE | 69,283 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 69,766 | 2,018,097 | SH | SOLE | 2,018,097 | 0 | 0 | ||
RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 10,250 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
RETROPHIN INC | NOTE 2.500% 9/1 | 761299AB2 | 474,750 | 45,000,000 | PRN | SOLE | 45,000,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 127,243 | 2,867,771 | SH | SOLE | 2,867,771 | 0 | 0 | ||
SANA BIOTECHNOLOGY INC | COM | 799566104 | 335 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
SC HEALTH CORP | *W EXP 99/99/999 | G78516401 | 945 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 1,148 | 66,655 | SH | SOLE | 66,655 | 0 | 0 | ||
SIGILON THERAPEUTICS INC | COM | 82657L107 | 2,794 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
SILK RD MED INC | COM | 82710M100 | 17,226 | 340,100 | SH | SOLE | 340,100 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 74,171 | 13,412,552 | SH | SOLE | 13,412,552 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 356,808 | 4,849,912 | SH | SOLE | 4,849,912 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 26,100 | 671,978 | SH | SOLE | 671,978 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 6,037 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
TALIS BIOMEDICAL CORP | COM | 87424L108 | 3,212 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 41,127 | 1,296,416 | SH | SOLE | 1,296,416 | 0 | 0 | ||
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 9,548 | 470,440 | SH | SOLE | 470,440 | 0 | 0 | ||
TCR2 THERAPEUTICS INC | COM | 87808K106 | 6,918 | 313,300 | SH | SOLE | 313,300 | 0 | 0 | ||
THERAPEUTICS ACQUISITION COR | COM CL A | 88339T103 | 15,765 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
THERAPEUTICSMD INC | COM | 88338N107 | 3,685 | 2,750,000 | SH | SOLE | 2,750,000 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 82,362 | 3,298,419 | SH | SOLE | 3,298,419 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 29,272 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 16,787 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
VBI VACCINES INC CDA | COM NEW | 91822J103 | 171,182 | 55,042,465 | SH | SOLE | 55,042,465 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 24,151 | 2,888,889 | SH | SOLE | 2,888,889 | 0 | 0 | ||
VERRICA PHARMACEUTICALS INC | COM | 92511W108 | 54,698 | 3,610,412 | SH | SOLE | 3,610,412 | 0 | 0 | ||
VERU INC | COM | 92536C103 | 47,963 | 4,451,342 | SH | SOLE | 4,451,342 | 0 | 0 | ||
VIATRIS INC | COM | 92556V106 | 14,032 | 1,004,419 | SH | SOLE | 1,004,419 | 0 | 0 | ||
VIEWRAY INC | COM | 92672L107 | 3,270 | 751,748 | SH | SOLE | 751,748 | 0 | 0 | ||
VINCERX PHARMA INC | COM NEW | 92731L106 | 5,790 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
VINCERX PHARMA INC | *W EXP 12/24/202 | 92731L114 | 1,212 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
VYNE THERAPEUTICS INC | COM | 92941V209 | 46,368 | 6,773,954 | SH | SOLE | 6,773,954 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 9,219 | 515,042 | SH | SOLE | 515,042 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 136,769 | 4,330,868 | SH | SOLE | 4,330,868 | 0 | 0 |